BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18855979)

  • 1. Bioinformatics analysis of metastasis-related proteins in hepatocellular carcinoma.
    Song PM; Zhang Y; He YF; Bao HM; Luo JH; Liu YK; Yang PY; Chen X
    World J Gastroenterol; 2008 Oct; 14(38):5816-22. PubMed ID: 18855979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and analysis of altered alpha1,6-fucosylated glycoproteins associated with hepatocellular carcinoma metastasis.
    Dai Z; Liu YK; Cui JF; Shen HL; Chen J; Sun RX; Zhang Y; Zhou XW; Yang PY; Tang ZY
    Proteomics; 2006 Nov; 6(21):5857-67. PubMed ID: 17068759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MALDI imaging-based classification of hepatocellular carcinoma and non-malignant lesions in fibrotic liver tissue.
    Marquardt C; Tolstik T; Bielecki C; Kaufmann R; Crecelius AC; Schubert US; Settmacher U; Stallmach A; Dirsch O
    Z Gastroenterol; 2015 Jan; 53(1):33-9. PubMed ID: 25594705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering the protein-protein interaction network regulating hepatocellular carcinoma metastasis.
    Qin G; Dang M; Gao H; Wang H; Luo F; Chen R
    Biochim Biophys Acta Proteins Proteom; 2017 Sep; 1865(9):1114-1122. PubMed ID: 28627476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysing protein-protein interaction networks of human liver cancer cell lines with diverse metastasis potential.
    Zhou HJ; Liu YK; Li Z; Yun D; Shun QL; Guo K
    J Cancer Res Clin Oncol; 2007 Sep; 133(9):663-72. PubMed ID: 17458561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis on metastasis-associated proteins of human hepatocellular carcinoma tissues.
    Song HY; Liu YK; Feng JT; Cui JF; Dai Z; Zhang LJ; Feng JX; Shen HL; Tang ZY
    J Cancer Res Clin Oncol; 2006 Feb; 132(2):92-8. PubMed ID: 16261346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.
    Sun S; Lee NP; Poon RT; Fan ST; He QY; Lau GK; Luk JM
    Liver Int; 2007 Oct; 27(8):1021-38. PubMed ID: 17845530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proteomic analysis on metastasis-associated proteins of hepatocellular carcinoma tissues].
    Song HY; Liu YK; Cui JF; Zhang LJ; Dai Z; Feng JT; Feng JX; Shen HL; Yang PY
    Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):331-4. PubMed ID: 15918964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-dimensional electrophoresis map of the human hepatocellular carcinoma cell line, HCC-M, and identification of the separated proteins by mass spectrometry.
    Seow TK; Ong SE; Liang RC; Ren EC; Chan L; Ou K; Chung MC
    Electrophoresis; 2000 May; 21(9):1787-813. PubMed ID: 10870966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics Analysis Reveals Distinct Molecular Characteristics of Hepatitis B-Related Hepatocellular Carcinomas from Very Early to Advanced Barcelona Clinic Liver Cancer Stages.
    Kong FY; Wei X; Zhou K; Hu W; Kou YB; You HJ; Liu XM; Zheng KY; Tang RX
    PLoS One; 2016; 11(7):e0158286. PubMed ID: 27454179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new versatile peptide-based size exclusion chromatography platform for global profiling and quantitation of candidate biomarkers in hepatocellular carcinoma specimens.
    Lee HJ; Na K; Kwon MS; Park T; Kim KS; Kim H; Paik YK
    Proteomics; 2011 May; 11(10):1976-84. PubMed ID: 21500349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of Pokemon-regulated proteins in hepatocellular carcinoma using mass spectrometry-based multiplex quantitative proteomics.
    Bi X; Jin Y; Gao X; Liu F; Gao D; Jiang Y; Liu H
    Eur J Mass Spectrom (Chichester); 2013; 19(2):111-21. PubMed ID: 24261083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative proteomics and molecular mechanical analysis in CDA-II induced therapy of LCI-D20 hepatocellular carcinoma model.
    Fan HZ; Liu H; Zhang C; Gao DM; Xue Q; Chen J; Sun RX; Liu YK; Yang PY
    J Cancer Res Clin Oncol; 2009 Apr; 135(4):591-602. PubMed ID: 18853186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphoproteomic analysis of the highly-metastatic hepatocellular carcinoma cell line, MHCC97-H.
    Tian M; Cheng H; Wang Z; Su N; Liu Z; Sun C; Zhen B; Hong X; Xue Y; Xu P
    Int J Mol Sci; 2015 Feb; 16(2):4209-25. PubMed ID: 25690035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global profiling of proteolytically modified proteins in human metastatic hepatocellular carcinoma cell lines reveals CAPN2 centered network.
    Shen C; Yu Y; Li H; Yan G; Liu M; Shen H; Yang P
    Proteomics; 2012 Jun; 12(12):1917-27. PubMed ID: 22623320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.
    Qin LX; Tang ZY
    J Cancer Res Clin Oncol; 2004 Sep; 130(9):497-513. PubMed ID: 15205947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
    Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
    Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.